These reports, besides illustrating the mechanism whereby PGE-2 induces immunoevasion, provide evidence for a strategy that may lead to tumor eradication by combining PGE-2 inhibition and anti-PD-1 blockade. Here, PDCD1 is linked to neoplasm.